Public Charity

FUND FOR OPHTHALMIC KNOWLEDGE INC C/O DAVID H ABRAMSON MD

FUND FOR OPHTHALMIC KNOWLEDGE INC C/O DAVID H ABRAMSON MD is a Public Charity headquartered in NEW YORK, NY. Financial data from the 2024 filing: $70K revenue, $136K expenses, $777K total assets. IRS filings disclose 9 grants awarded by this foundation, totaling roughly $1.2M.

EIN: 134171637 NEW YORK, NY Latest filing: 2024
Total Revenue$70K
Total Expenses$136K
Total Assets$777K
Grants Given9
Grant Total$1.2M
Filing Years2020–2024

Mission

SEE STATEMENT ON SCHEDULE O

Sample Grants Given

MEMORIAL SLOAN KETTERING CANCER CENTER
NEW YORK, NY · 2024
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
$56,128
MEMORIAL SLOAN KETTERING CANCER CENTER
NEW YORK, NY · 2023
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
$198,692
MEMORIAL SLOAN KETTERING CANCER CENTER
NEW YORK, NY · 2022
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
$161,184
MEMORIAL SLOAN KETTERING CANCER CENTER
NEW YORK, NY · 2021
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
$56,184
MEMORIAL SLOAN KETTERING CANCER CENTER
NEW YORK, NY · 2020
SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
$157,056

Showing up to 5 of 9 total records — full history available with membership.

Officers & Directors

DIRECTOR Allan Abramson Md
DIRECTOR & PRESIDENT David H Abramson Md
DIRECTOR & VP & TREASURER Hilary Cruz-Abrams Bamphrn
DIRECTOR Joseph Gold Md
DIRECTOR Nicholas Grumbach Md
DIRECTOR Robin Cruz-Abrams

Officer compensation and complete director data available with membership.

Top Grant Purposes

SUPPORTED RESEARCH ON EYE CANCER PERFORMED AT MSKCC: STUDIES ON CELL FREE DNA IN PLASMA OF RETINOBLASTOMA PATIENTS, STUDIES OF CHOROIDAL INVASION IN RETINOBLASTOMA, STUDIES OF THE USE OF INTRARTERIAL CHEMOTHERAPY IN HISTIOCYTOSIS, STUDIES ON EFFICACY AND TOXICITY OF INTRAVITREAL TOPOTECAN FOR EYE CANCER.
$629,244 5 grants
MEMORIAL SLOAN-KETTERING CANCER CENTER ("MSKCC") ($215,795) -A) SUPPORT THE RESEARCH AND CLINICAL STUDIES FOR RETINOBLASTOMA ($150,000): THESE FUNDS SUPPORTED THE RESEARCH CONDUCTED AT MSK DURING THE YEAR. IT RESULTED IN 16 PUBLICATIONS IN PEER REVIEWED JOURNALS INCLUDING THE BRITISH JOURNAL OF OPHTHALMOLOGY, OPHTHALMOLOGY, AMERICAN JOURNAL OF OPHTHALMOLOGY, NEOPLASIA, PLOS1, INT J OF RETINA AND VITREOUS, JAMA OPHTHALMOLOGY, OPHTHALMIC GENETICS AND IOVS. THE TOTAL NUMBER OF AUTHORS SUPPORTED BY THESE FUNDS IN 2018 WAS 52.B) CYCLE FOR SURVIVAL ($55,000): DONATION TO THE CYCLE CHARITY-THE YEARLY FUND RAISER AT MSK TO SUPPORT RESEARCH IN RARE CANCERS.C) RESEARCH EQUIPMENT AND SUPPLIES ($10,795): COMPUTERS, STATISTICIANS, REPRINTS, PRODUCTION OF SCIENTIFIC ARTICLES AND ONGOING RESEARCH AT MSK, INCLUDING CHARGES BY LABS FOR PROCESSING SPECIMENS FOR RESEARCH.
$206,960 1 grant
SUPPORTED BASIC AND CLINICAL RESEARCH IN CANCER PERFORMED AT MSKCC AND RESULTING IN MORE THAN 15 PEER REVIEWED SCIENTIFIC PUBLICATIONS.
$204,804 1 grant
$60,000 TO SUPPORT ONGOING RESEARCH OF SCOTT BRODIE, MD AT MOUNT SINAI SCHOOL OF MEDICINE (DEPARTMENT OF OPHTHALMOLOGY); $5,000 TO SUPPORT THE MT. SINAI CLINICAL GLAUCOMA FELLOWSHIP.
$65,000 1 grant
SUPPORT THE CYCLE FOR SURVIVAL ($50,000); RETINOBLASTOMA WEB DOMAIN FOR MSKCC ($5,950); RESEARCH SUPPLIES ($2,295) AND DR. MARK SCHATTNER MD RESEARCH FUND IN CANCER ($1,000).
$53,295 1 grant

Financial Trends

Year Revenue Expenses Assets
2024 $70K $136K $777K
2023 $52K $253K $815K
2022 $105K $255K $966K
2021 $183K $140K $1.3M
2020 $74K $197K $1.2M

Between 2020 and 2024, reported annual revenue declined from $74K to $70K (-6%), with total assets most recently reported at $777K.

Interactive year-over-year charts and full filing details available with membership.

Grant Geography

Grants from this foundation were reported to recipients in NY.

NY

Full geographic grant map with state-by-state breakdown available with membership.

See the full picture for FUND FOR OPHTHALMIC KNOWLEDGE INC C/O DAVID H ABRAMSON MD

Complete financials, all 9 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 498,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
Start Free Trial → Log In
7-day free trial Cancel any time